15 St.allen International Breast G Cancer …

1 7 Preliminary ProgrammeFor information about the updated programme please visit WienTourismus / Claudio Alessandri 15th St. Gallen International BreastCancer conference 2017 Primary Therapy of Early Breast CancerEvidence, Controversies, Consensus15 18 March 2017, Austria Center, Vienna / 14:57 InvitationThe International Scientific Committee and the local organizers invite you to another (15th) St. Gallen- Breast Cancer conference in Vienna/ Austria. Experts of virtually all major Breast Cancer cooperative groups and centers world-wide, actively engaged in basic and clinical research as well as in clinical management of Breast Cancer , will again present their latest data, critically reviewed by leading specialists in the field.

2 The conference closes as usual with an update of the widely acknowledged and highly regarded St. Gallen International Consensus on the present optimal primary treatment of early Breast Cancer . conference Co-Chairs 2017 Giuseppe Curigliano(Milano/Italy)Michael Gnant(Vienna/Austria)Martine Piccart-Gebhart(Brussels/Belgium)Meredit h Regan (Boston, MA/USA)Hans-J rg Senn(St. Gallen/Switzerland)Beat Th rlimann(St. Gallen/Switzerland)Eric Winer (Boston, MA/USA)Faculty 2017 Around 70 invited top Breast Cancer specialistsfrom major Breast Cancer study groups and 3000-4000 Breast Cancer oriented surgeons,gynaecologists, medical- and radio-oncologists,pathologists, epidemiologists and Breast cancernurses from around 90 countries worldwide.

3 VenueAustria Center Vienna (ACV)Bruno-Kreisky-Platz 1AT-1220 Vienna / AustriaImportant deadlines1 June 2016: Opening early registration on August 2016: Opening poster abstract submission and grant application on December 2016: Closing poster abstract submission and grant application10 January 2017: Closing early rate registration1 March 2017: Closing late registration, on-site fee appliesRegistrationRegister on (registration opening 1 June 2016) and visit our website for updated information regarding program, faculty and feesRegular participantResidents, nursesEarly bird fee from1 June 2016750.

4 450. Late fee from10 January 2017900. 650. Onsite fee from1 March 20171050. 1050. Contact for General information, industrial exhibition, abstract submission, individual and group registration, transport and accommodation, technical management Mondial Congress & EventsMondial GmbH & Co. KGOperngasse 20b AT-1040 Vienna/Austriaphone +43 (0) 1 58804 0, fax +43 (0) 1 58804 forScientific programme, sponsorship and satellite symposiaSt. Gallen Oncology Conferences SG-BCC 2017 c/o Tumor and Breast Center ZeTuPRorschacherstrasse 150CH-9006 St.

5 Gallen/Switzerlandphone: +41 (0) 71 243 00 32, fax +41 (0) 245 68 INVITATION AND GENERAL 14:57 Wednesday, 15 March h Satellite symposia (3) h Opening: Welcome, Award Ceremony, Opening Address Award lecture by the St. Gallen 2017 St. Gallen- International Breast Cancer Award h Session 1: News since St. Gallen 2015: De-escalating and escalating treatment according to stage and Breast Cancer subtype Chairs: Martine Piccart-Gebhart (Belgium), Beat Th rlimann (Switzerland) h Coffee h Session 2: Biology of Breast Cancer I: Overcoming resistance to treatment in early Breast Cancer Chairs: Fabrice Andr (France), Peter Dubsky (Austria)Networking h Welcome Ap ro (on the premises of the Austria Center Vienna), open to all registered personsThursday, 16 March 2017 h Session 3: Biology of Breast Cancer II.

6 Intratumoral heterogeneity and therapeutic implications Chairs: Jonas Bergh (Sweden), C. Kent Osborne (USA) h Coffee break, posters I, h Session 4: Genetics and prevention of invasive Breast Cancer Chairs: Jack Cuzick (United Kingdom), Judy Garber (USA) h Special lecture I Chair: Giuseppe Curigliano (Italy) Immunotherapy for Breast Cancer - hope or hype? (Nora Disis, USA) h Lunch break, posters I, satellite symposium, h Session 5: Research translation into clinic: Targetable pathways on the horizon Chairs: Marco Colleoni (Italy), Clifford Hudis (USA) h Coffee break, posters I, h Session 6: Pathology for risk stratisfication and treatment tailoring Chairs: Herv Bonnefoi (France), Giuseppe Viale (Italy) h Satellite symposiumPRELIMINARY PROGRAMME(subject to changes) 14:57 Friday, 17 March 2017 h Session 7: Surgery of early Breast Cancer .

7 De-escalation and escalation Chairs: Michael Gnant (Austria), Emiel Rutgers (The Netherlands), Zhiming Shao (PR China) h Coffee break, posters II, h Session 8: Radiotherapy in early Breast Cancer 2017: De-escalation and escalation Chairs: Roberto Orecchia (Italy), Felix Sedlmayer (Austria) h Special lecture II Chair: Martine Piccart-Gebhart (Belgium) Extrapolating data from clinical trials to real life: Estimating magnitude of clinical benefit in early Breast Cancer (Clifford Hudis, USA) h Lunch break, posters II, satellite symposium, h Session 9: Primary and adjuvant systemic therapy of early Breast Cancer I Chairs: Daniel F.

8 Hayes (USA), Jens Huober (Germany) h Coffee break, posters II, h Session 10: Primary and and adjuvant systemic therapy of early Breast Cancer II Chairs: Olivia Pagani (Switzerland), Kathleen Pritchard (Canada) h Satellite symposiumSaturday, 18 March h Session 11: St. Gallen International consensus session on the optimal primary treatment of Breast Cancer 2017: Seeking consensus on evidence and opinions Chairs: Giuseppe Curigliano (Italy, Eric Winer (USA) Scientific secretaries and consensus co-authors: Harold J. Burstein (USA), Marco Colleoni (Italy) Peter Dubsky (Austria), Sibylle Loibl (Germany) Meredith Regan (USA), Beat Th rlimann (Switzerland) h h Adjourn Annual Meeting 2017 of the International Breast Cancer Study Group (IBCSG) (on special invitation for IBCSG members and their registered guests)PRELIMINARY PROGRAMME(subject to changes) 14:57)